OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting STAT3 in cancer and autoimmune diseases
Tohid Gharibi, Zohreh Babaloo, Arezoo Hosseini, et al.
European Journal of Pharmacology (2020) Vol. 878, pp. 173107-173107
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Marta Menegazzi, Rachele Campagnari, Mariarita Bertoldi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5171-5171
Open Access | Times Cited: 97

Contribution of STAT3 to the pathogenesis of COVID-19
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh
Microbial Pathogenesis (2021) Vol. 154, pp. 104836-104836
Open Access | Times Cited: 83

Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity
Georgios Sogkas, Faranaz Atschekzei, Ignatius Ryan Adriawan, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1122-1140
Open Access | Times Cited: 62

Tea polyphenol EGCG inhibited colorectal-cancer-cell proliferation and migration via downregulation of STAT3
Ke-Wang Luo, Jun Xia, Bao‐Hui Cheng, et al.
Gastroenterology report (2020) Vol. 9, Iss. 1, pp. 59-70
Open Access | Times Cited: 54

Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma
Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, S. Chandra Nayak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188574-188574
Closed Access | Times Cited: 51

Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
Tamir Baram, Linor Rubinstein-Achiasaf, Hagar Ben-Yaakov, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 48

Signal transducer and activator of transcription 3 signaling in tumor immune evasion
Luying Zhang, Kamil Kuča, You Li, et al.
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107969-107969
Closed Access | Times Cited: 45

A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice
Kelsey A. Toth, Erica G. Schmitt, Ana Kolicheski, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 8
Closed Access | Times Cited: 7

Intrinsic STING Switches off Pathogenetic Programs of Th1 Cells to Inhibit Colitis
Wenjing Yang, Tianming Yu, Guangxi Zhou, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 5, pp. 1161-1179
Open Access | Times Cited: 15

Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis
Neda Dadgar, Christopher Sherry, Jenna Zimmerman, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Targeting the STAT3 pathway with STAT3 degraders
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 5

Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect
Yuhan Wang, Junsha An, Jianbo Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target
Delphine Trochet, Marc Bitoun
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 30

Research progress of STAT3-based dual inhibitors for cancer therapy
Xiao-Juan Yang, Lu Xu, Yang Li, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 91, pp. 117382-117382
Closed Access | Times Cited: 12

Blue light irradiation inhibits the M2 polarization of the cancer-associated macrophages in colon cancer
Toshiaki Yoshimoto, Masaaki Nishi, Shohei Okikawa, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4

Targeting STAT3 for Cancer Therapy: Focusing on Y705, S727, or Dual Inhibition?
Kyli Berkley, Julian Zalejski, Ashutosh Sharma
Cancers (2025) Vol. 17, Iss. 5, pp. 755-755
Open Access

MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers
Kazem Nejati‐Koshki, Mohammad Reza Alivand, AmirAhmad Arabzadeh
Pathology - Research and Practice (2021) Vol. 223, pp. 153452-153452
Closed Access | Times Cited: 26

Role of STAT3 Transcription Factor in Pathogenesis of Bronchial Asthma
А. А. Никольский, I.P. Shilovskiy, Ekaterina Barvinskaia, et al.
Biochemistry (Moscow) (2021) Vol. 86, Iss. 11, pp. 1489-1501
Closed Access | Times Cited: 25

The anti-inflammatory effects of Hedyotis diffusa Willd on SLE with STAT3 as a key target
Li Xu, Ying Li, Jinjun Ji, et al.
Journal of Ethnopharmacology (2022) Vol. 298, pp. 115597-115597
Open Access | Times Cited: 17

Piperine suppresses inflammatory fibroblast-like synoviocytes derived from rheumatoid arthritis patients Via NF-κB inhibition
Qoyama Noel Baito, Halmat M. Jaafar, Talar Ahmad Merza Mohammad
Cellular Immunology (2023) Vol. 391-392, pp. 104752-104752
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top